| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911148 | Lung Cancer | 2014 | 6 Pages |
Abstract
Our results show that a screening algorithm based on an IHC detection of ROS1 fusion proteins, confirmed if positive or doubtful by a ROS1 break-apart FISH assay, is pertinent in advanced “triple negative” lung adenocarcinomas, since the prevalence of ROS1-positive cases in this selected population reaches 7.4% in our series.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lénaïg Mescam-Mancini, Sylvie Lantuéjoul, Denis Moro-Sibilot, Isabelle Rouquette, Pierre-Jean Souquet, Clarisse Audigier-Valette, Jean-Christophe Sabourin, Chantal Decroisette, Linda Sakhri, Elisabeth Brambilla, Anne McLeer-Florin,